This inventor holds 14 USPTO granted patents and 1 published patent application. Top assignees: Medical Diagnostic Laboratories, LLC, Medical Diagnostic Lab, LLC. Active years: 2010-2020.
Company Filing History:
13 out of 80 
1 out of 1 Years Active: 2010-2020
Title: Innovations of Jason Trama in Bladder Cancer Detection
Introduction
Jason Trama is an accomplished inventor based in Burlington, NJ, with a notable portfolio of 14 patents. His work primarily focuses on medical diagnostics, particularly in the field of bladder cancer detection. Trama's innovative approaches have the potential to significantly impact patient outcomes through early diagnosis.
Latest Patents
One of Trama's latest patents involves the ELISA detection of urine DEK to predict and diagnose bladder cancer in humans. This invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. The methods and compositions for detection utilize mAb 260-6F9F6 as the detection antibody and mAb 16-2C9C3 as the capture antibody. The ELISA assay is designed to yield a high sensitivity of less than 50 ng/mL. The presence of DEK in urine is instrumental in predicting or diagnosing the occurrence of bladder cancer in humans.
Career Highlights
Throughout his career, Jason Trama has worked with several organizations, including Medical Diagnostic Laboratories, LLC. His contributions to the field of medical diagnostics have been recognized for their innovative approaches and practical applications.
Collaborations
Trama has collaborated with notable professionals in the field, including Martin E Adelson and Eli Mordechai. These collaborations have further enhanced the development and implementation of his innovative diagnostic methods.
Conclusion
Jason Trama's work in the detection of bladder cancer through innovative methods showcases his commitment to advancing medical diagnostics. His contributions are paving the way for improved patient care and early detection of critical health issues.